Making aspirin in the lab looks simple on paper, but pharmaceutical synthesis is about more than obtaining a product. Chemists also ask how much waste is produced, how efficiently atoms end up in the desired molecule, whether catalysts can improve the route, and how a candidate drug moves from discovery to approval.
Use the PDF for classwork, homework or revision. It includes key ideas, activities, questions, an extend task and success-criteria proof.
A student performs an aspirin synthesis and obtains crystals of product. They conclude: “The reaction was successful, so the process must also be sustainable.”
📚 Core Content
Aspirin, or acetylsalicylic acid, is synthesised from salicylic acid and acetic anhydride. This is an esterification-style reaction in which the aspirin product is formed along with ethanoic acid.
The reaction is commonly carried out with an acid catalyst and gentle heating, then the product is crystallised and purified. In the lab this reaction is often taught as a manageable model of pharmaceutical synthesis.
Wrong: Concentration and amount of solute are the same thing.
Right: Concentration is amount per unit volume; the same amount of solute can produce different concentrations in different volumes.
This workflow emphasises that synthesis is not just one reaction equation. Product quality depends on reaction conditions, isolation, crystallisation, and drying as well as the chemistry itself.
Making a candidate molecule is only the start of pharmaceutical development. A successful drug must also pass a long sequence of testing and regulatory stages.
Green chemistry asks chemists to design processes that minimise waste and hazard from the start, rather than cleaning up problems afterward.
Green-chemistry evaluation needs numbers, not just impressions. Two useful measures are atom economy and E-factor.
These measures are related, but they are not identical. Atom economy focuses on how reaction atoms are distributed among products, while E-factor reflects the practical mass of waste generated in the process.
Catalysts matter in pharmaceutical chemistry because they can increase reaction rate and improve selectivity without being used up in the overall process.
In aspirin synthesis, an acid catalyst helps the reaction proceed more effectively. More broadly, catalysts can reduce required energy input, improve conversion to the desired product, and help lower waste. That makes them important tools for greener synthesis routes.
📊 Data Interpretation
| Route | Atom economy | Waste produced / g | Product obtained / g | E-factor |
|---|---|---|---|---|
| Route A | 74% | 6.0 | 3.0 | 2.0 |
| Route B | 62% | 12.0 | 3.0 | 4.0 |
| Route C | 74% | 3.0 | 3.0 | 1.0 |
Route C is strongest overall because it combines high atom economy with the lowest E-factor. Route A is better than Route B, but still produces more waste than Route C. This shows why one metric alone is not enough.
✏️ Worked Examples
Given: A reaction produces aspirin as the desired product and ethanoic acid as the only other product. Assume the total molar mass of all products is 240 g mol-1 and aspirin has molar mass 180 g mol-1.
Find: Atom economy.
Method:
atom economy = (MW of desired product / total MW of all products) × 100%
atom economy = (180 / 240) × 100%
atom economy = 75%
Answer: The atom economy is 75%, meaning 75% of the product-side atom mass appears in the desired aspirin.
Given: A synthesis produces 4.0 g of product and 10.0 g of waste.
Find: E-factor.
Method:
E-factor = mass of waste / mass of product
E-factor = 10.0 / 4.0
E-factor = 2.5
Answer: The E-factor is 2.5, so 2.5 g of waste are produced for every 1 g of product.
🧠 Activities
1 A route has desired product molar mass 150 g mol-1 and total molar mass of all products 250 g mol-1. Calculate atom economy.
2 A reaction produces 5.0 g of product and 7.5 g of waste. Calculate E-factor.
3 Which is more sustainable: a route with atom economy 80% and E-factor 1.0, or a route with atom economy 65% and E-factor 3.0? Explain briefly.
1 Identify the reagents and products in aspirin synthesis and state the type of reaction.
2 Explain why a catalyst can improve sustainability even though it does not become part of the final balanced equation products.
3 Why does a successful synthesis still need preclinical testing, clinical trials and regulatory approval before a drug can be supplied widely?
1. Which pair of reagents is used to synthesise aspirin in this course?
2. Which sequence correctly describes pharmaceutical development?
3. What does a higher atom economy generally indicate?
What is NOT does a higher atom economy generally indicate?
4. Which statement best describes E-factor?
5. Why can catalysts improve sustainability in pharmaceutical synthesis?
1. Describe the synthesis of aspirin from salicylic acid and acetic anhydride, including reagents, conditions, products and reaction type. 4 marks
2. Explain the difference between atom economy and E-factor, and why both are useful when evaluating a synthesis route. 5 marks
3. Evaluate the sustainability of an aspirin synthesis route that has moderate yield, atom economy of 75%, E-factor of 3.0 and requires a catalyst. In your answer, refer to waste, atom use and the role of the catalyst. 5 marks
Return to the opening claim that a successful synthesis must also be sustainable, and refine it using the green-chemistry tools from this lesson.
1. Atom economy = (150 / 250) × 100% = 60%.
2. E-factor = 7.5 / 5.0 = 1.5.
3. The route with atom economy 80% and E-factor 1.0 is more sustainable because it uses atoms more efficiently and generates less waste per gram of product.
1. The reagents are salicylic acid and acetic anhydride. The products are aspirin and ethanoic acid. The reaction is an esterification-style acetylation process.
2. A catalyst can improve sustainability by increasing rate and selectivity, lowering energy demand and helping reduce wasted reagents or by-products even though it is not consumed overall.
3. Synthesis success is not enough because a drug must still be shown to be safe and effective through preclinical testing, clinical trials and regulatory approval.
1. B — aspirin is synthesised from salicylic acid and acetic anhydride.
2. D — this is the correct sequence from discovery to approval.
3. A — higher atom economy means more atoms end in the desired product.
4. C — E-factor is mass of waste divided by mass of product.
5. B — catalysts can improve efficiency and selectivity without being consumed.
Q1 (4 marks): Aspirin is synthesised by reacting salicylic acid with acetic anhydride, usually under acid-catalysed conditions with gentle heating. The desired product is acetylsalicylic acid, and ethanoic acid is also formed. The reaction is an esterification-style acetylation process. After reaction, aspirin can be crystallised, filtered and dried.
Q2 (5 marks): Atom economy measures the fraction of product-side atom mass that appears in the desired product. E-factor measures the mass of waste produced per mass of product obtained. Atom economy is useful because it shows how well atoms are directed into the wanted molecule at the reaction level. E-factor is useful because it reflects the practical waste burden of the process. Both are needed because a route may look good by one metric but still generate too much waste overall.
Q3 (5 marks): This route has some strengths but is not ideal. An atom economy of 75% suggests that a reasonable proportion of atoms end up in the desired aspirin, so the route is moderately efficient in atom use. However, an E-factor of 3.0 means the process still generates 3 g of waste for every 1 g of product, which is a significant waste burden. The catalyst is a positive feature because it can improve rate and selectivity and may reduce energy use or unwanted side products. Overall, the route is workable and moderately sustainable, but there is still room to improve waste reduction and overall process efficiency.
Tick when you've finished the activities and checked your answers.